Andrés Fernández
Research Subjects
Andrés Fernández has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aurelio Hernández-Laín
Department of Neuropathology, Hospital Universitario 12 de Octubre, Madrid, Spain
1 shared publication - Belén de Andrés
Immunobiology Department, Carlos III Health Institute, Madrid, Spain
1 shared publication - Eva Cano
Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 29016 Madrid, Spain
1 shared publication Javier Cotrina
Chronic Disease Programme, Madrid, Spain
1 shared publication- Juan Miguel Redondo
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid
1 shared publication - Katia Urso
R&D Department, ITF Research Pharma S.L.U., Alcobendas, Spain
1 shared publication
Latest Publications
- Open Access
- 27 June 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-14
NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells
Calcium/Calcineurin/Nuclear Factor of Activated T cells (Ca/CN/NFAT) signalling pathway is the main calcium (Ca2+) dependent signalling pathway involved in the homeostasis of brain tissue. Here, we study the presence of NFATc members in human glioma by using U251 cells and a collection of primary human glioblastoma (hGB) cell lines. We show that NFATc3 member is the predominant member. Furthermore, by using constitutive active NFATc3 mutant and shRNA lentiviral vectors to achieve specific silencing of this NFATc member, we describe cytokines and molecules regulated by this pathway which are required for the normal biology of cancer cells. Implanting U251 in an orthotopic intracranial assay, we show that specific NFATc3 silencing has a role in tumour growth. In addition NFATc3 knock-down affects both the proliferation and migration capacities of glioma cellsin vitro. Our data open the possibility of NFATc3 as a target for the treatment of glioma.
- 27 June 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-14
Open AccessNFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells
Calcium/Calcineurin/Nuclear Factor of Activated T cells (Ca/CN/NFAT) signalling pathway is the main calcium (Ca2+) dependent signalling pathway involved in the homeostasis of brain tissue. Here, we study the presence of NFATc members in human glioma by using U251 cells and a collection of primary human glioblastoma (hGB) cell lines. We show that NFATc3 member is the predominant member. Furthermore, by using constitutive active NFATc3 mutant and shRNA lentiviral vectors to achieve specific silencing of this NFATc member, we describe cytokines and molecules regulated by this pathway which are required for the normal biology of cancer cells. Implanting U251 in an orthotopic intracranial assay, we show that specific NFATc3 silencing has a role in tumour growth. In addition NFATc3 knock-down affects both the proliferation and migration capacities of glioma cellsin vitro. Our data open the possibility of NFATc3 as a target for the treatment of glioma.